| AGEs | Advanced glycation end products |
| AKT | Protein kinase B |
| ALT | Alanine aminotransferase |
| ARRIVE | Animal Research: Reporting of In Vivo Experiments |
| AST | Aspartate aminotransferase |
| BrdU | 5-bromo-2′-deoxyuridine |
| BUN | Blood urea nitrogen |
| CD | Cluster of differentiation |
| CI | Confidence interval |
| CMC | Carboxymethyl cellulose |
| DAG | Diacylglycerol |
| DNA | Deoxyribonucleic acid |
| ECM | Extracellular matrix |
| EGF | Epidermal growth factor |
| EGR-1 | Early growth response protein 1 |
| ERK | Extracellular signal-regulated kinase |
| FGF | Fibroblast growth factor |
| GRADE | Grading of Recommendations Assessment, Development and Evaluation |
| HB-EGF | Heparin-binding epidermal growth factor |
| HIF-1α | Hypoxia-inducible factor 1 alpha |
| HO-1 | Heme oxygenase 1 |
| IF | Immunofluorescence |
| IGF-I | Insulin-like growth factor I |
| IHC | Immunohistochemistry |
| IL | Interleukin |
| IP3 | Inositol 1,4,5-trisphosphate |
| IWGDF | International Working Group on the Diabetic Foot |
| MAPK | Mitogen-activated protein kinase |
| MD | Mean difference |
| MDA | Malondialdehyde |
| MEK | Mitogen-activated protein kinase kinase |
| MeSH | Medical Subject Headings |
| MMP | Matrix metalloproteinase |
| NF-κB | Nuclear factor kappa B |
| NLRP3 | NLR family pyrin domain-containing protein 3 |
| NOD | Non-obese diabetic |
| NR | Not reported |
| Nrf2 | Nuclear factor erythroid 2-related factor 2 |
| OSF | Open Science Framework |
| PBS | Phosphate-buffered saline |
| PCNA | Proliferating cell nuclear antigen |
| PDGF | Platelet-derived growth factor |
| PDGF-BB | Platelet-derived growth factor-BB |
| PDGFR | Platelet-derived growth factor receptor |
| PEG | Polyethylene glycol |
| PICOS | Population, Intervention, Comparator, Outcomes, and Study Design |
| PI3K | Phosphoinositide 3-kinase |
| PIP3 | Phosphatidylinositol 3,4,5-trisphosphate |
| PLGA | Poly(lactic-co-glycolic acid) |
| PLC-γ | Phospholipase C gamma |
| PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analyses |
| RAF | Rapidly accelerated fibrosarcoma kinase |
| RAGE | Receptor for advanced glycation end-products |
| RAS | Rat sarcoma small gtpase |
| REML | Restricted maximum likelihood |
| rhPDGF-BB | Recombinant human platelet-derived growth factor-BB |
| ROS | Reactive oxygen species |
| SOD1 | Superoxide dismutase 1 |
| STZ | Streptozotocin |
| SWiM | Synthesis Without Meta-Analysis |
| SYRCLE | Systematic Review Centre for Laboratory Animal Experimentation |
| TGF | Transforming growth factor |
| TIMP | Tissue inhibitor of metalloproteinases |
| VEGF | Vascular endothelial growth factor |
| WRAHPS | Wound Reporting in Animal and Human Preclinical Studies |